Literature DB >> 1304876

The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.

R A DeLa Cadena1, R W Colman.   

Abstract

The histidine-glycine-rich region of the light chain of cleaved high molecular weight kininogen (HK) is thought to be responsible for binding to negatively charged surfaces and initiation of the intrinsic coagulation, fibrinolytic, and kinin-forming systems. However, the specifically required amino acid sequences have not been delineated. An IgG fraction of a monoclonal antibody (MAb) C11C1 to the HK light chain was shown to inhibit by 66% the coagulant activity and by 57% the binding of HK to the anionic surface of kaolin at a concentration of 1.5 microM and 27 microM, respectively. Proteolytic fragments of HK were produced by successive digestion with human plasma kallikrein and factor XIa (FXIa). Those polypeptides that bound tightly (Kd = 0.77 nM) to a C11C1 affinity column were eluted at pH 3.0 and purified by membrane filtration. On 15% SDS polyacrylamide electrophoresis, the approximate M(r) was 7.3 kDa (range 6.2-8.1 kDa). Based on N-terminal sequencing, this polypeptide (1(2)), which extends from the histidine residue 459 to a lysine at position 505, 509, 511, 512, 515, or 520, inhibits by 50% the coagulant activity expressed by HK at a concentration of 22 microM. The synthetic peptide HGLGHGH representing the N-terminal of the 1(2)) fragment was synthesized, tested, and found at 4 mM to inhibit the procoagulant activity of HK 50%. A synthetic heptadecapeptide, HGLGHGHEQQHGLGHGH (residues 459-475) included within the 1(2) fragment, and with the ability to bind zinc, inhibited 50% of the HK coagulant activity at a concentration of 325 microM in the absence and presence of added Zn2+ (30 microM). The specific binding of 125I-HK to a negatively charged surface (kaolin) was inhibited 50% by unlabeled HK (5 microM). HGLGHGH, at a concentration of 7.0 mM, inhibited the binding to kaolin by 50%. The heptadecapeptide inhibited the specific binding of 125I-HK to kaolin by 50%, at a concentration of 2.3 mM, in the absence of Zn2+. In contrast, when Zn2+ was added, the concentration to achieve 50% inhibition decreased to 630 microM, indicating that Zn2+ was required to attain a favorable conformation for binding. Moreover, the 1(2) fragment was found to inhibit 50% of the 125I-HK binding to kaolin at a concentration of 380 microM. These results suggest that residues contained within the 1(2) fragment, notably HGLGHGHEQQHGLGHGH, serves as a primary structural feature for binding to a negatively charged surface.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1304876      PMCID: PMC2142082          DOI: 10.1002/pro.5560010115

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  23 in total

1.  Functional characterization of human blood coagulation factor XIa using hybridoma antibodies.

Authors:  D Sinha; A Koshy; F S Seaman; P N Walsh
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

Review 2.  Surface-mediated defense reactions. The plasma contact activation system.

Authors:  R W Colman
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

3.  The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein.

Authors:  N Ikari; T Sugo; S Fujii; H Kato; S Iwanaga
Journal:  J Biochem       Date:  1981-06       Impact factor: 3.387

4.  Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.

Authors:  D M Kerbiriou; J H Griffin
Journal:  J Biol Chem       Date:  1979-12-10       Impact factor: 5.157

5.  Binding of coagulation factor XI to washed human platelets.

Authors:  J S Greengard; M J Heeb; E Ersdal; P N Walsh; J H Griffin
Journal:  Biochemistry       Date:  1986-07-01       Impact factor: 3.162

6.  Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI.

Authors:  J F Tait; K Fujikawa
Journal:  J Biol Chem       Date:  1987-08-25       Impact factor: 5.157

7.  Cleavage of human high molecular weight kininogen by factor XIa in vitro. Effect on structure and function.

Authors:  C F Scott; L D Silver; A D Purdon; R W Colman
Journal:  J Biol Chem       Date:  1985-09-05       Impact factor: 5.157

8.  Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.

Authors:  T Shimada; H Kato; S Iwanaga
Journal:  J Biochem       Date:  1987-10       Impact factor: 3.387

9.  Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.

Authors:  R J Mandle; R W Colman; A P Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

10.  The binding of high molecular weight kininogen to cultured human endothelial cells.

Authors:  F van Iwaarden; P G de Groot; B N Bouma
Journal:  J Biol Chem       Date:  1988-04-05       Impact factor: 5.157

View more
  9 in total

1.  Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.

Authors:  Jia Fan; Muy-Kheng M Tea; Chuan Yang; Li Ma; Qing H Meng; Tony Y Hu; Christian F Singer; Mauro Ferrari
Journal:  J Proteome Res       Date:  2016-04-26       Impact factor: 4.466

2.  Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.

Authors:  R W Colman; R A Pixley; S Najamunnisa; W Yan; J Wang; A Mazar; K R McCrae
Journal:  J Clin Invest       Date:  1997-09-15       Impact factor: 14.808

3.  High-molecular-weight kininogen fragments stimulate the secretion of cytokines and chemokines through uPAR, Mac-1, and gC1qR in monocytes.

Authors:  Mohammad M Khan; Harlan N Bradford; Irma Isordia-Salas; Yuchuan Liu; Yi Wu; Ricardo G Espinola; Berhane Ghebrehiwet; Robert W Colman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-08-10       Impact factor: 8.311

4.  Staphylococcus aureus induces release of bradykinin in human plasma.

Authors:  E Mattsson; H Herwald; H Cramer; K Persson; U Sjöbring; L Björck
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

Review 6.  The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases.

Authors:  W Stöcker; F Grams; U Baumann; P Reinemer; F X Gomis-Rüth; D B McKay; W Bode
Journal:  Protein Sci       Date:  1995-05       Impact factor: 6.725

7.  Human mast cell tryptase isoforms: separation and examination of substrate-specificity differences.

Authors:  S S Little; D A Johnson
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  Antifungal activities of peptides derived from domain 5 of high-molecular-weight kininogen.

Authors:  Andreas Sonesson; Emma Andersson Nordahl; Martin Malmsten; Artur Schmidtchen
Journal:  Int J Pept       Date:  2011-09-14

9.  Polyphosphate, Zn2+ and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting.

Authors:  Yuqi Wang; Ivan Ivanov; Stephanie A Smith; David Gailani; James H Morrissey
Journal:  J Thromb Haemost       Date:  2019-09-18       Impact factor: 16.036

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.